152 related articles for article (PubMed ID: 20407444)
1. Insulin-like growth factor-binding protein 7 alters the sensitivity to interferon-based anticancer therapy in hepatocellular carcinoma cells.
Tomimaru Y; Eguchi H; Wada H; Noda T; Murakami M; Kobayashi S; Marubashi S; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Br J Cancer; 2010 May; 102(10):1483-90. PubMed ID: 20407444
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-21 induces resistance to the anti-tumour effect of interferon-α/5-fluorouracil in hepatocellular carcinoma cells.
Tomimaru Y; Eguchi H; Nagano H; Wada H; Tomokuni A; Kobayashi S; Marubashi S; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
Br J Cancer; 2010 Nov; 103(10):1617-26. PubMed ID: 20978511
[TBL] [Abstract][Full Text] [Related]
3. IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma.
Tomimaru Y; Eguchi H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Umeshita K; Kim T; Wakasa K; Doki Y; Mori M; Nagano H
Int J Cancer; 2012 Jan; 130(2):319-27. PubMed ID: 21328580
[TBL] [Abstract][Full Text] [Related]
4. Genes associated with human hepatocellular carcinoma cell chemosensitivity to 5-fluorouracil plus interferon-alpha combination chemotherapy.
Moriyama M; Hoshida Y; Kato N; Otsuka M; Yoshida H; Kawabe T; Omata M
Int J Oncol; 2004 Nov; 25(5):1279-87. PubMed ID: 15492816
[TBL] [Abstract][Full Text] [Related]
5. miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells.
Tomokuni A; Eguchi H; Tomimaru Y; Wada H; Kawamoto K; Kobayashi S; Marubashi S; Tanemura M; Nagano H; Mori M; Doki Y
Biochem Biophys Res Commun; 2011 Nov; 414(4):675-80. PubMed ID: 21982769
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma.
Chen D; Yoo BK; Santhekadur PK; Gredler R; Bhutia SK; Das SK; Fuller C; Su ZZ; Fisher PB; Sarkar D
Clin Cancer Res; 2011 Nov; 17(21):6693-701. PubMed ID: 21908579
[TBL] [Abstract][Full Text] [Related]
7. Interferon regulatory factor-1 gene abnormality and loss of growth inhibitory effect of interferon-alpha in human hepatoma cell lines.
Tada S; Saito H; Tsunematsu S; Ebinuma H; Wakabayashi K; Masuda T; Ishii H
Int J Oncol; 1998 Dec; 13(6):1207-16. PubMed ID: 9824633
[TBL] [Abstract][Full Text] [Related]
8. Combination of IFN-alpha and 5-fluorouracil induces apoptosis through IFN-alpha/beta receptor in human hepatocellular carcinoma cells.
Kondo M; Nagano H; Wada H; Damdinsuren B; Yamamoto H; Hiraoka N; Eguchi H; Miyamoto A; Yamamoto T; Ota H; Nakamura M; Marubashi S; Dono K; Umeshita K; Nakamori S; Sakon M; Monden M
Clin Cancer Res; 2005 Feb; 11(3):1277-86. PubMed ID: 15709199
[TBL] [Abstract][Full Text] [Related]
9. Role of p53 in the inhibitory effects of interferon-alpha subtypes on proliferation of hepatocellular carcinoma cells.
Fujioka N; Ariyasu T; Arai N; Ariyasu H; Yamamoto S; Tanimoto T; Ikegami H; Ikeda M; Ohta T; Fukuda S; Kurimoto M
Biomed Res; 2006 Oct; 27(5):219-26. PubMed ID: 17099286
[TBL] [Abstract][Full Text] [Related]
10. Interferon-beta is more potent than interferon-alpha in inhibition of human hepatocellular carcinoma cell growth when used alone and in combination with anticancer drugs.
Damdinsuren B; Nagano H; Sakon M; Kondo M; Yamamoto T; Umeshita K; Dono K; Nakamori S; Monden M
Ann Surg Oncol; 2003 Dec; 10(10):1184-90. PubMed ID: 14654475
[TBL] [Abstract][Full Text] [Related]
11. Reduction in p48-ISGFgamma levels confers resistance to interferon-alpha2a in MHCC97 cells.
Wu WZ; Sun HC; Gao YQ; Li Y; Wang L; Zhou K; Liu KD; Iliakis G; Tang ZY
Oncology; 2004; 67(5-6):428-40. PubMed ID: 15714000
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of IGF1-R overcomes IGFBP7-induced chemotherapy resistance in T-ALL.
Bartram I; Erben U; Ortiz-Tanchez J; Blunert K; Schlee C; Neumann M; Heesch S; Baldus CD
BMC Cancer; 2015 Oct; 15():663. PubMed ID: 26450156
[TBL] [Abstract][Full Text] [Related]
13. Identification of the genes chemosensitizing hepatocellular carcinoma cells to interferon-α/5-fluorouracil and their clinical significance.
Sakabe T; Tsuchiya H; Kanki K; Azumi J; Gonda K; Mizuta Y; Yamada D; Wada H; Shomori K; Nagano H; Shiota G
PLoS One; 2013; 8(2):e56197. PubMed ID: 23457527
[TBL] [Abstract][Full Text] [Related]
14. Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma.
Noda T; Nagano H; Takemasa I; Yoshioka S; Murakami M; Wada H; Kobayashi S; Marubashi S; Takeda Y; Dono K; Umeshita K; Matsuura N; Matsubara K; Doki Y; Mori M; Monden M
Br J Cancer; 2009 May; 100(10):1647-58. PubMed ID: 19401692
[TBL] [Abstract][Full Text] [Related]
15. PTK787/ZK222584 combined with interferon alpha and 5-fluorouracil synergistically inhibits VEGF signaling pathway in hepatocellular carcinoma.
Katsura Y; Wada H; Murakami M; Akita H; Hama N; Kawamoto K; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Umeshita K; Doki Y; Mori M; Nagano H
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S517-26. PubMed ID: 23508585
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of insulin-like growth factor-binding protein 7 in cisplatin-resistant non-small cell lung cancer.
Okamura J; Huang Y; Moon D; Brait M; Chang X; Kim MS
Cancer Biol Ther; 2012 Feb; 13(3):148-55. PubMed ID: 22277373
[TBL] [Abstract][Full Text] [Related]
17. Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma.
Hou J; Zhou Y; Zheng Y; Fan J; Zhou W; Ng IO; Sun H; Qin L; Qiu S; Lee JM; Lo CM; Man K; Yang Y; Yang Y; Yang Y; Zhang Q; Zhu X; Li N; Wang Z; Ding G; Zhuang SM; Zheng L; Luo X; Xie Y; Liang A; Wang Z; Zhang M; Xia Q; Liang T; Yu Y; Cao X
Cancer Cell; 2014 Jan; 25(1):49-63. PubMed ID: 24360797
[TBL] [Abstract][Full Text] [Related]
18. Circulating cell-free DNA of methylated insulin-like growth factor-binding protein 7 predicts a poor prognosis in hepatitis B virus-associated hepatocellular carcinoma after hepatectomy.
Li F; Qiao CY; Gao S; Fan YC; Chen LY; Wang K
Free Radic Res; 2018 Apr; 52(4):455-464. PubMed ID: 29463155
[TBL] [Abstract][Full Text] [Related]
19. Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma.
Ou DL; Shyue SK; Lin LI; Feng ZR; Liou JY; Fan HH; Lee BS; Hsu C; Cheng AL
Oncotarget; 2015 Sep; 6(29):27953-65. PubMed ID: 26172295
[TBL] [Abstract][Full Text] [Related]
20. Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells.
Wada H; Nagano H; Yamamoto H; Noda T; Murakami M; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Doki Y; Mori M
BMC Cancer; 2009 Oct; 9():361. PubMed ID: 19821965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
